Applications of human organoids in the personalized treatment for digestive diseases

Abstract Digestive system diseases arise primarily through the interplay of genetic and environmental influences; there is an urgent need in elucidating the pathogenic mechanisms of these diseases and deploy personalized treatments. Traditional and long-established model systems rarely reproduce eit...

Full description

Bibliographic Details
Main Authors: Qinying Wang, Fanying Guo, Yutao Jin, Yanlei Ma
Format: Article
Language:English
Published: Nature Publishing Group 2022-09-01
Series:Signal Transduction and Targeted Therapy
Online Access:https://doi.org/10.1038/s41392-022-01194-6
_version_ 1811201142106882048
author Qinying Wang
Fanying Guo
Yutao Jin
Yanlei Ma
author_facet Qinying Wang
Fanying Guo
Yutao Jin
Yanlei Ma
author_sort Qinying Wang
collection DOAJ
description Abstract Digestive system diseases arise primarily through the interplay of genetic and environmental influences; there is an urgent need in elucidating the pathogenic mechanisms of these diseases and deploy personalized treatments. Traditional and long-established model systems rarely reproduce either tissue complexity or human physiology faithfully; these shortcomings underscore the need for better models. Organoids represent a promising research model, helping us gain a more profound understanding of the digestive organs; this model can also be used to provide patients with precise and individualized treatment and to build rapid in vitro test models for drug screening or gene/cell therapy, linking basic research with clinical treatment. Over the past few decades, the use of organoids has led to an advanced understanding of the composition of each digestive organ and has facilitated disease modeling, chemotherapy dose prediction, CRISPR-Cas9 genetic intervention, high-throughput drug screening, and identification of SARS-CoV-2 targets, pathogenic infection. However, the existing organoids of the digestive system mainly include the epithelial system. In order to reveal the pathogenic mechanism of digestive diseases, it is necessary to establish a completer and more physiological organoid model. Combining organoids and advanced techniques to test individualized treatments of different formulations is a promising approach that requires further exploration. This review highlights the advancements in the field of organoid technology from the perspectives of disease modeling and personalized therapy.
first_indexed 2024-04-12T02:15:50Z
format Article
id doaj.art-8a8452f5f31f40dd8cfb72d117b1a229
institution Directory Open Access Journal
issn 2059-3635
language English
last_indexed 2024-04-12T02:15:50Z
publishDate 2022-09-01
publisher Nature Publishing Group
record_format Article
series Signal Transduction and Targeted Therapy
spelling doaj.art-8a8452f5f31f40dd8cfb72d117b1a2292022-12-22T03:52:15ZengNature Publishing GroupSignal Transduction and Targeted Therapy2059-36352022-09-017113010.1038/s41392-022-01194-6Applications of human organoids in the personalized treatment for digestive diseasesQinying Wang0Fanying Guo1Yutao Jin2Yanlei Ma3Department of Colorectal Surgery, Fudan University Shanghai Cancer CenterSchool of Clinical Medicine, Shanghai Medical College, Fudan UniversityDepartment of Colorectal Surgery, Fudan University Shanghai Cancer CenterDepartment of Colorectal Surgery, Fudan University Shanghai Cancer CenterAbstract Digestive system diseases arise primarily through the interplay of genetic and environmental influences; there is an urgent need in elucidating the pathogenic mechanisms of these diseases and deploy personalized treatments. Traditional and long-established model systems rarely reproduce either tissue complexity or human physiology faithfully; these shortcomings underscore the need for better models. Organoids represent a promising research model, helping us gain a more profound understanding of the digestive organs; this model can also be used to provide patients with precise and individualized treatment and to build rapid in vitro test models for drug screening or gene/cell therapy, linking basic research with clinical treatment. Over the past few decades, the use of organoids has led to an advanced understanding of the composition of each digestive organ and has facilitated disease modeling, chemotherapy dose prediction, CRISPR-Cas9 genetic intervention, high-throughput drug screening, and identification of SARS-CoV-2 targets, pathogenic infection. However, the existing organoids of the digestive system mainly include the epithelial system. In order to reveal the pathogenic mechanism of digestive diseases, it is necessary to establish a completer and more physiological organoid model. Combining organoids and advanced techniques to test individualized treatments of different formulations is a promising approach that requires further exploration. This review highlights the advancements in the field of organoid technology from the perspectives of disease modeling and personalized therapy.https://doi.org/10.1038/s41392-022-01194-6
spellingShingle Qinying Wang
Fanying Guo
Yutao Jin
Yanlei Ma
Applications of human organoids in the personalized treatment for digestive diseases
Signal Transduction and Targeted Therapy
title Applications of human organoids in the personalized treatment for digestive diseases
title_full Applications of human organoids in the personalized treatment for digestive diseases
title_fullStr Applications of human organoids in the personalized treatment for digestive diseases
title_full_unstemmed Applications of human organoids in the personalized treatment for digestive diseases
title_short Applications of human organoids in the personalized treatment for digestive diseases
title_sort applications of human organoids in the personalized treatment for digestive diseases
url https://doi.org/10.1038/s41392-022-01194-6
work_keys_str_mv AT qinyingwang applicationsofhumanorganoidsinthepersonalizedtreatmentfordigestivediseases
AT fanyingguo applicationsofhumanorganoidsinthepersonalizedtreatmentfordigestivediseases
AT yutaojin applicationsofhumanorganoidsinthepersonalizedtreatmentfordigestivediseases
AT yanleima applicationsofhumanorganoidsinthepersonalizedtreatmentfordigestivediseases